Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

7,983 public trials 1,815 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Intratumoral N17350 in Advanced Solid Tumors

NCT07339176

Conditions
Breast Diseases, Breast Neoplasms, Breast Neoplasms, Triple-Negative, +33 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCLA - Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

NCT06745908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare - Orange Coast Medical Center Fountain Valley, California, United States
  • OPN Healthcare INC Glendale, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT07155174

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Yale University School of Medicine /ID# 278181 New Haven, Connecticut, United States
  • Ocala Oncology Center /ID# 278269 Ocala, Florida, United States
  • Moffitt Cancer Center /ID# 277573 Tampa, Florida, United States
  • Fort Wayne Medical Oncology And Hematology /ID# 277336 Fort Wayne, Indiana, United States
View all 61 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

NCT07513376

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Smilow Cancer Center at Yale-New Haven ( Site 3253) New Haven, Connecticut, United States
  • Billings Clinic ( Site 3255) Billings, Montana, United States
  • NHO Revive Research Institute, LLC ( Site 3218) Lincoln, Nebraska, United States
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 3207) Reno, Nevada, United States
View all 42 locations
View Trial Details
Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

NCT06095583

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations
  • Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
  • Xiangya Hospital Central South University Changsha, Hunan, China
  • The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China
  • The First Hospital of China Medical University Shenyang, Liaoning, China
View all 76 locations
View Trial Details
Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

NCT07195695

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ClinRé 001-022 (Premier Cancer Care and Infusion Center) Fresno, California, United States
  • OPN Healthcare, Inc. Glendale, California, United States
  • University of California Irvine Irvine, California, United States
  • Sutter Health Roseville, California, United States
View all 199 locations
View Trial Details

Related conditions